Search
Alterity Therapeutics Ltd
ATHEAdd to Watchlist
5.360USD
-0.100-1.83%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
81.54MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
2
analysts
Buy
Current Rating
12.667
Target Price
+159.03%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Alterity Therapeutics Ltd
ATHE
2
Beigene Ltd
ONC
27
Ionis Pharmaceuticals Inc
IONS
27
CRISPR Therapeutics AG
CRSP
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Alterity Therapeutics Ltd's price target?
Analysts forecast that Alterity Therapeutics Ltd's price target is USD 11.00, with the highest forecast at USD 12.00 and the lowest forecast at USD 10.00.
How have Alterity Therapeutics LtdATHE's recent earnings per share performed?
The market expectation was USD -0.25, while Alterity Therapeutics LtdATHE's earnings per share (EPS) for the previous quarter was USD -0.55. EPS for the next quarter is expected at USD -0.06.
What is the analyst rating for Alterity Therapeutics Ltd?
Based on the ratings of Alterity Therapeutics Ltd's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.